I-Metastase yintoni eyenza umdlavuza ube yingozi. Ukukhula kweseli okungalawulwayo kuphazamisa umsebenzi wesigqeba esiqhelekileyo. Ezinye izitho, ezinjenge- lymph nodes umzekelo, ziqhubeka nokusebenza kakuhle, nangona xa umdlavuza usasazeka. Ngoko ke, i-lymph node yasasazeka yindlela encinci yingozi yomhlaza we-prostate. Kwesinye siphelo sesiganeko sesibindi, esincinci kakhulu.
Ubunzima beethambo zesifo, iindawo eziqhelekileyo zesifo somhlaza wesifo seprotate sisasazeka, sithetha malunga neendlela eziphakathi kwe-node metastase kunye ne-metastases yesibindi. Ngethamsanqa, i-foast isifo esinqabileyo kakhulu xa umdlavuza wesifo sesifo sesifo sesifo sesifo se-prostate sifumaneka okokuqala. Ubunzima bezilwanyana zihlala zenzeka emva kweminyaka emininzi yokwelashwa okuqhubekayo.
Izinto ezichaphazela ingozi yeeNtsholongwane zeCarstate Cancer
Xa uthetha ngomhlaza wesibeletho, kuba igama elithi "umhlaza" lisoloko lenza uloyiko olukhulu, kufuneka lihlale likhunjulwa ukuba ezininzi iintlobo zisezantsi kwaye azizange zisasaze. La mabakala aphantsi "amachiza" ayahlukana kwaye amela uhlobo oluhluke ngokupheleleyo lwesifo esingenakukwazi ukuhlaziya. Nangona kunjalo, xa kuxubusha uhlobo lwesifo somhlaza wesifo seprotate esinamandla okusasazeka, ezi zinto zichaphazela ukuba kuyingozi kangakanani:
- Isayithi sokusasazeka, yiphi ilungu eye yaphuhlisa izidumbu
- Ubungakanani bokusasazeka, iimali ezinkulu zomhlaza zibuhlungu kakhulu.
- Isantya sokwanda kweseli se-tumor esiboniswe ngethuba le-PSA eliphindwe kabini
- Ukusebenza kwonyango olukhoyo, into ehambelana nenani lezonyango zangaphambili eziye zazanywa
Njengoko kuphawuliwe ngasentla, isibindi asixhomekekanga kwi-metastatic invasion ngaphezu kwethambo okanye i-lymph nodes. Ukongezelela, kuba izibilini zesibindi zivame ukuvela kumadoda anezifo eziphambili, ukukhula kwama-tumor kudla.
Kananjalo, unyango olusetyenziswa ngokuqhelekileyo njengonyango lwe-hormone kunye ne-chemotherapy sele liye lalingelwa. Ukufunyanwa kwesibindi semitha, ngoko ke, uphuhliso olubi kakhulu.
Ukufumanisa iMetastases
Ubunzima bezilwanyana ziqala ukukhankanywa xa uvavanyo lwegazi lwe-hepatic blood panel luyinto engavamile. Uphando ngenxa yeziphumo zegazi ezingaqhelekanga zihlala zikhokelela ekusebenzeni kwe-CT scan okanye i-MRI scan, ekhokelela ekufumaneni i-metastases kwisibindi. Ngaphandle koko, iskrini sinokuthatha iindawo ezingaqhelekanga kwisibindi kwindlela eqhelekileyo yokukhangela kwenkqubo eyenziwa njengengxenye yenkqubo yokujonga rhoqo.
Izinyango Zonyango
I-Hormone therapy kunye neLupron, iZytiga, ne-Xtandi, okanye i-chemotherapy ne-Taxotere, i-Jevtana ne-Carboplatin, yindlela efanelekileyo yokwelapha isifo se-metastasis yesibindi. Nangona kunjalo, ezi zonyango ziye zazama kwaye zilahlekelwa ngempumelelo. Ekubeni ukuhluleka kwesibindi kufana nokufa, ukukhula komdlavuza wesibeletho kwisibindi kufuneka kugqitywe, kungakhathaliseki ukuba isifo sifaka njani kuwo wonke umzimba, oko kukuthi, amathambo kunye ne-lymph nodes.
Izifundo zingafundwa kumdlavuza wekoloni kuba isibindi semastastimas ukusuka kumdlavuza we-colon metastatic are common.
Ionyango zomhlaza wekolon eziqeshwe ngokubanzi zibandakanya ukuhlinzwa, ukutshabalaliswa kwemitha kunye nokukhutshwa kwegazi kwi-isibindi ngokuqulunqwa kwemibhobho, yonke imiphumo eyahlukileyo. Ngoku kutshanje, i-microspheres e-radioactive ivunyiwe ukuba ijokelelwe kwi-blood supply yesibindi. I-microspheres ibizwa ngokuba yi-SIR-Spheres. Ziye zabonisa ukusebenza okuphawulekayo kunye nemiphumo emibi kakhulu.
Umhlaza wesifo seprotate kunye nomdlavuza wekoloni unokufumana ukufana okufanayo kumbane. Ngaloo ndlela, kunengqiqo ukuqwalasela ukuba ii-SIR-Spheres ziya kuba nefuthe lokumelana nokuqhubela phambili komhlaza wesibeletho kwisibindi.
Ngokwenziwa kwam, siye sancoma i-SIR-Spheres kwizigulane zomhlaza wesifo seprotate ezinesibindi semitha. Iziphumo zikhuthaze ngokuphuculiswa okuphawulekayo kokusinda xa kuthelekiswa namava ethu angaphambili kwiisigulane somhlaza wesifo seprotate esinezibilini zesibindi. Isiphumo sezigulane ezithandathu eziphathwe nge-SIR-Spheres zicwangciselwe ukuba zichazwe kwintetho kwi-2016 yeSigcrostestinal Cancers-ASCO Symposium.